Final Rule Expands Access to Meds for Nonregistered Practitioners’ Treatment of Opioid Use Disorder

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Final Rule Expands Access to Meds for Nonregistered Practitioners’ Treatment of Opioid Use Disorder

Dennis Tosh

August 11, 2023 at 14:54:47 ET

The DEA issued an immediately-in-effect final rule that will expand access to medications for the treatment of opioid use disorder (OUD) by allowing a practitioner not registered with the agency to dispense not more than a three-day supply of narcotic drugs rather than a one-day supply to initiate maintenance or detoxification treatment (88 Fed. Reg. 53377, Aug. 8, 2023). The Easy ... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

Final Rule Expands Access to Meds for Nonregistered Practitioners’ Treatment of Opioid Use Disorder

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT